[Health Tips] New Cancer Vaccine Phase 3 Trial: Efficacy, Side Effects, and Hope
On August 19, 2026, drugmakers Merck and Moderna announced something oncologists have been waiting decades for: a personalized cancer vaccine had succeeded in a randomized, late-stage Phase 3 clinical trial. It's the first time this has happened…